72
Views
17
CrossRef citations to date
0
Altmetric
Case Report

Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma

, , , , &
Pages 685-688 | Published online: 20 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

W Riley Stroman & Jeffrey G Gross. (2014) Review of the latest treatments for proliferative diabetic retinopathy. Expert Review of Ophthalmology 9:5, pages 413-424.
Read now
Donghyun Jee & Won Ki Lee. (2012) Inhibitory Effect of Intravitreal Injection of Bevacizumab on Nerve Growth Factor. Current Eye Research 37:5, pages 408-415.
Read now

Articles from other publishers (15)

. (2021) Bevacizumab. Reactions Weekly 1845:1, pages 100-100.
Crossref
José Hernández-Jiménez, Antonio Martínez-Ortega, Antonio Salmerón-García, José Cabeza, José Carlos Prados, Raul Ortíz & Natalia Navas. (2018) Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles. International Journal of Biological Macromolecules 118, pages 511-524.
Crossref
Huseyin Gursoy, Mustafa Deger Bilgec, Nazmiye Erol, Hikmet Basmak & Ertugrul Colak. (2017) The analysis of posterior segment findings in term and premature infants using RetCam images. International Ophthalmology 38:5, pages 1879-1886.
Crossref
M.N. Ndiaye-Sow, S.M. Seck, M. Dieng, M. Diakhaté-Diouf, G.A. Agboton & N.N. Gueye. (2018) Profil du glaucome néovasculaire chez les patients sénégalais. Journal Français d'Ophtalmologie 41:7, pages 637-641.
Crossref
Inmaculada Suárez, Antonio Salmerón-García, José Cabeza, Luis Fermín Capitán-Vallvey & Natalia Navas. (2016) Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. Journal of Chromatography B 1032, pages 155-164.
Crossref
Minwen Zhou, Xun Xu, Xiulan Zhang & Xiaodong Sun. (2016) Clinical Outcomes of Ahmed Glaucoma Valve Implantation With or Without Intravitreal Bevacizumab Pretreatment for Neovascular Glaucoma: A Systematic Review and Meta-Analysis. Journal of Glaucoma 25:7, pages 551-557.
Crossref
Megan Kim, Chelsea Lee, Rachael Payne, Beatrice Y.J.T. Yue, Jin-Hong Chang & Hongyu Ying. (2015) Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review. Survey of Ophthalmology 60:6, pages 524-535.
Crossref
Jason Flamendorf & Howard F. Fine. (2014) Pharmacotherapy for Treatment and Prevention of Proliferative Diabetic Retinopathy. Current Ophthalmology Reports 2:4, pages 175-183.
Crossref
Hyoun Do HuhYong Seop HanIn Young ChungSeong Wook SeoJong Moon ParkJi Myong YooSeong Jae Kim. (2014) Comparision between Simultaneous Intracameral and Intravitreal Injection and Intravitreal Injection of Bevacizumab in Neovascular Glaucoma. Journal of the Korean Ophthalmological Society 55:7, pages 1039.
Crossref
Fiona Roberts & Chee Koon ThumFiona Roberts & Chee Koon Thum. 2014. Lee's Ophthalmic Histopathology. Lee's Ophthalmic Histopathology 51 85 .
L. Kodjikian. (2013) Traitement du glaucome néovasculaire en 2012 : apport des anti-VEGF. Journal Français d'Ophtalmologie 36:5, pages 461-465.
Crossref
Elisabeth Wittström, Hans Holmberg, Charlotte Hvarfner & Sten Andréasson. (2011) Clinical and Electrophysiologic Outcome in Patients with Neovascular Glaucoma Treated with and without Bevacizumab. European Journal of Ophthalmology 22:4, pages 563-574.
Crossref
M. Paul, V. Vieillard, E. Roumi, A. Cauvin, M.C. Despiau, M. Laurent & A. Astier. (2012) Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration. Annales Pharmaceutiques Françaises 70:3, pages 139-154.
Crossref
Abdulrahman A. Alghadyan. (2011) Diabetic retinopathy – An update. Saudi Journal of Ophthalmology 25:2, pages 99-111.
Crossref
Mohammad BanifatemiM. Reza RazeghinejadHamid HosseiniAhmadreza Gholampour. (2011) Bevacizumab and Ocular Wound Healing After Primary Pterygium Excision. Journal of Ocular Pharmacology and Therapeutics 27:1, pages 17-21.
Crossref